Download
1 / 2
20 likes | 30 Views
Chronic Kidney Disease (CKD) is a syndrome where there are tenacious modifications in kidney structure, function, or with implications for the health of the individual. Examples of structural abnormalities encompass cysts, tumors, malformations, and atrophy, which can be evident on imaging.
E N D
Chronic Kidney Disease (CKD) is a syndrome where there are tenacious modifications in kidney structure, function, or with implications for the health of the individual. Examples of structural abnormalities encompass cysts, tumors, malformations, and atrophy, which can be evident on imaging. Chronic Kidney Disease Causes Chronic Kidney Disease develops when a disease impairs kidney function, causing kidney damage to worsen over numerous months or years. Diseases and conditions that cause chronic kidney disease include: type 1 or type 2 diabetes, high blood pressure, glomerulonephritis, interstitial nephritis, polycystic kidney disease, prolonged obstruction of the urinary tract, vesicoureteral reflux, and recurrent kidney infection, also named pyelonephritis. Chronic Kidney Disease Signs and Symptoms Signs and symptoms of Chronic Kidney Disease amplify over time if kidney damage progresses sluggishly. Symptoms of kidney disease may include: nausea, vomiting, loss of appetite, fatigue, and weakness, sleep problems, decreased mental sharpness, muscle twitches, and cramps, swelling of feet, and ankles, shortness of breath, and high blood pressure. Chronic Kidney Disease Epidemiology The findings from the National Institute of Diabetes and Digestive and Kidney Diseases Health Information Center suggest that the overall prevalence of Chronic Kidney Disease increased from 12% to 14% between 1988 and 1994 and from 1999 to 2004, but has remained nearly stable since 2004. The total prevailing population of Chronic Kidney Disease in the 7MM was 65,988,842 in 2017, during the study period 2017–2030. DelveInsight estimates show the highest Chronic Kidney Disease prevalent population is in the United States, with 37,809,570 cases in 2017. And the second most prevalent cases of Chronic Kidney Disease in 7MM were reported in Japan with 13,758,938 cases in 2017. Chronic Kidney Disease Treatment Options Depending on the underlying condition, some types of kidney disease can be treated. Frequently, even though there is no treatment. Treatment usually consists of measures to control symptoms, reduce complications, and slow the progress of the disease. The main treatments are lifestyle changes, medicine, dialysis, a kidney transplant. Chronic Kidney Disease Market
Within the rising Chronic Kidney Disease Market Scenario, several organizations are developing small molecule, orally-delivered drugs to block hypoxia-inducible, factor prolyl-hydroxylases (HIF-PHDs), and ultimately increase the production of red blood cells underneath natural oxygen levels. There are different types of medications available within the market. Available medicines cannot reverse Chronic Kidney Disease; however, they're used to treat complications and to sluggish further kidney damage. The key players involved in the Chronic Kidney Disease market are GlaxoSmithKline, Akebia Therapeutics, FibroGen/ Astellas Pharma/ AstraZeneca, Boehringer Ingelheim, Astra Zeneca, Tricida, Reata Pharmaceuticals, Corvidia Therapeutics, And others. The current Chronic Kidney Disease therapeutic landscape in the US is driven by several approved therapies. The market is estimated to be USD 8,190.58 Million in 2030. Market size shall increase during the forecast period (2020-2030), owing to the launch of forthcoming therapies. Among the 7MM, the US accounts for 51% of the overall market size, in USD, of Chronic Kidney Disease in 2030. EU-5 countries, Germany accounts for the largest market size for Chronic Kidney Disease followed by France.
